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It is well recognized that steroids are synthesized de novo in the brain (neurosteroids).
In addition, steroids circulating in the blood enter the brain. Steroids play numerous roles
in the brain, such as inﬂuencing neural development, adult neuroplasticity, behavior, neu-
roinﬂammation, and neurodegenerative diseases such as Alzheimer’s disease. In order to
understand the regulation and functions of steroids in the brain, it is important to directly
measure steroid concentrations in brain tissue. In this brief review, we discuss methods
for the detection and quantiﬁcation of steroids in the brain. We concisely present the
major advantages and disadvantages of different technical approaches at various exper-
imental stages: euthanasia, tissue collection, steroid extraction, steroid separation, and
steroid measurement. We discuss, among other topics, the potential effects of anesthe-
sia and saline perfusion prior to tissue collection; microdissection via Palkovits punch;
solid phase extraction; chromatographic separation of steroids; and immunoassays and
mass spectrometry for steroid quantiﬁcation, particularly the use of mass spectrometry
for “steroid proﬁling.” Finally, we discuss the interpretation of local steroid concentra-
tions, such as comparing steroid levels in brain tissue with those in the circulation (plasma
vs. whole blood samples; total vs. free steroid levels). We also present reference val-
ues for a variety of steroids in different brain regions of adult rats. This brief review
highlights some of the major methodological considerations at multiple experimental
stages and provides a broad framework for designing studies that examine local steroid
levels in the brain as well as other steroidogenic tissues, such as thymus, breast, and
prostate.
Keywords: corticosterone, estradiol, mouse, songbird, testosterone
INTRODUCTION
Steroids play many important physiological roles in the brain and
inﬂuence brain development, behavior, cognition, neuroplasticity,
and neuroinﬂammation (Baulieu, 1998; Sakamoto et al., 2001b;
Sorrells and Sapolsky, 2009). In addition to steroids that enter the
brain from the periphery, steroids are synthesized within the brain
itself (“neurosteroids”; Corpéchot et al., 1981). Neurosteroids
can be synthesized de novo from cholesterol or from circulating
inactive precursors (Compagnone and Mellon, 2000; Schmidt
et al., 2008; Do Rego et al., 2009). Because the brain is both a
producer and a target of steroids, it is of great interest and util-
ity to measure endogenous steroid levels in speciﬁc brain regions.
Measurement of local steroid levels allows for comparisons among
different brain regions, as well as comparisons between brain and
blood. Such comparisons are useful in determining which tissues
are synthesizing or metabolizing steroids (Schmidt and Soma,
2008; Hojo et al., 2009; Konkle and McCarthy, 2011). Indeed,
the presence of high pregnenolone and dehydroepiandrosterone
(DHEA) concentrations in the brain, and low concentrations in
the plasma, of gonadectomized and adrenalectomized rats was the
ﬁrst evidence that suggested steroid production in the brain (Cor-
péchot et al., 1981). High local steroid levels, along with studies
of steroidogenic enzyme mRNA, protein, and activity in the brain,
have demonstrated that the brain functions as a steroid-synthetic
organ (Schmidt et al., 2008; Taves et al., 2011).
The conceptual leap that permitted the brain to be consid-
ered a source (rather than merely a target) of steroid hormones
meant that measuring peripheral steroid levels in the blood was
no longer sufﬁcient for understanding steroid actions in the brain.
Determining the steroid level required for induction of a par-
ticular behavior, for example, involves addressing the contribu-
tions of steroids of both peripheral and central origin. To add to
the complexity, peripheral steroids that enter the brain are con-
verted into both inactive metabolites and more potent steroids
(Mellon and Grifﬁn, 2002). Since the expression and activity of
steroidogenic enzymes determines the steroidal milieu of different
brain regions, understanding the distribution and regulation of
steroidogenic enzymes in the central nervous system is a major
www.frontiersin.org September 2011 | Volume 2 | Article 39 | 1
Taves et al. Brain steroid measurement
step forward in estimating local steroid concentrations (Do Rego
et al., 2009). Indeed, the majority of papers on this topic have
measured steroidogenic enzymes in the brain, rather than the
products of these enzymes (i.e., the steroids themselves). How-
ever, the aggregate result of steroid synthesis and metabolism in
the brain and steroid uptake from the blood can only be deter-
mined via empirical measurements of steroid concentrations in
discrete brain regions.
Measuring steroids in brain tissue presents a number of tech-
nical challenges. These challenges include: the high lipid content
of brain tissue (requiring good sample preparation to avoid assay
interference; Rash et al., 1980); the high spatial heterogeneity of
the brain (resulting in small tissue amounts; Charlier et al., 2010);
low steroid concentrations, in some cases (Gomez-Sanchez et al.,
2005); ability of steroids to freely diffuse across cell membranes
(due to their hydrophobic nature); unique steroids that are absent
in the periphery (e.g., 17α-estradiol; Toran-Allerand et al., 2005);
and rapid changes in steroid production andmetabolism (Balthaz-
art and Ball, 2006). In this brief review, we discuss methodological
considerations that address or reduce these technical challenges,
and we also discuss the interpretation of tissue steroid concen-
trations. For a more general and comprehensive guide to steroid
analysis,we direct readers to the excellent text edited by Makin and
Gower (2010). Although here we focus on steroids in brain tissue,
the general principles discussed are also relevant for the measure-
ment of steroids in various other organs and tissues (Taves et al.,
2011).
SAMPLE COLLECTION
STUDY SPECIES
Building upon the initial description of neurosteroid synthesis
in the mammalian brain (Corpéchot et al., 1981; Le Goascogne
et al., 1987), subsequent work has identiﬁed neurosteroid synthe-
sis across vertebrate species, including ﬁsh (Forlano et al., 2001;
Sakamoto et al., 2001a; Diotel et al., 2011), amphibians (Mensah-
Nyagan et al., 1996; Takase et al., 1999; Matsunaga et al., 2004;
Bruzzone et al., 2010), and birds (Tsutsui et al., 2000; Soma et al.,
2004; London et al., 2006; Saldanha et al., 2011). The high levels of
steroidogenic enzyme expression and activity (and corresponding
high levels of steroids) in the brains of non-mammalian species
are a major advantage in the study of neurosteroids (Goodson
et al., 2005; Do Rego et al., 2009; Saldanha et al., 2009; Diotel et al.,
2010). In addition, because many birds are diurnal and terres-
trial, they are highly amenable to ﬁeld work. This allows studies
of neurosteroids in a natural and ecologically relevant context and
studies of how neurosteroids regulate natural behaviors (Soma
and Wingﬁeld, 2001; Soma, 2006; Soma et al., 2008; Newman and
Soma, 2009; Pradhan et al., 2010b). Comparative work has shown
that neurosteroid production is conserved across vertebrates, and
thus appears to be a general characteristic of the vertebrate brain
(Callard et al., 1978), including the human brain (Stoffel-Wagner,
2001; Yu et al., 2002).
INDIRECT MEASUREMENT OF BRAIN STEROID LEVELS
There are several strategies to indirectly assess brain steroid lev-
els. Some of these approaches allow for repeated sampling from
individual subjects, either in different contexts or in real-time
during experiments. One method of indirectly estimating brain
steroid levels involves collecting blood leaving the brain (i.e., from
the jugular vein) and comparing this to blood from another
source (e.g., carotid artery, brachial vein, or heart). If steroid
levels are higher in blood from the jugular vein, then this sug-
gests production of these steroids in the brain (Schlinger and
Arnold, 1992, 1993; Saldanha and Schlinger, 1997; Chin et al.,
2008; Newman et al., 2008b; Charlier et al., 2009; Newman and
Soma, 2011). To our knowledge, this approach has only been
used in studies of songbirds but might prove useful in other
species as well. Clearly, this approach is indirect and cannot reveal
the absolute concentrations of steroids in speciﬁc brain regions.
Nonetheless, this approach can be useful for determining rela-
tive changes in whole brain steroid production, and it permits
repeated sampling from subjects. However, note that stress can
rapidly alter steroid concentrations in the jugular blood (Newman
et al., 2008b).
Cerebrospinal ﬂuid (CSF) can also be used to indirectly esti-
mate the neural steroidalmilieu (Guazzo et al., 1996). For example,
in humans, CSF steroid levels are altered in patients with neu-
rological diseases such as Alzheimer’s disease (Kim et al., 2003).
However, collecting CSF samples of sufﬁcient volume from small
animals (e.g., mice) is a more difﬁcult obstacle.
Microdialysis allows quantiﬁcation of changing steroid levels
in a speciﬁc brain region (Saleh et al., 2004; Droste et al., 2008;
Remage-Healey et al., 2008). Artiﬁcial CSF is perfused into the
brain through a microdialysis probe, and dialysate is collected
across a membrane. This extremely powerful technique can be
used to measure temporal changes in steroid levels at a spe-
ciﬁc location in the brain of a freely behaving subject. Another
advantage is that subjects require minimal handling at the time
of sample collection. A disadvantage is that steroid levels are
measured in only a single region at a time. Moreover, steroid
recoveries across the dialysis membrane in vitro are generally
low (often <10%; e.g., Remage-Healey et al., 2008), and this
affects the minimum time windows required for dialysate col-
lection (often 5–30min) in order to have a detectable amount of
steroid. Steroid recoveries across the dialysis membrane in vivo
are very difﬁcult to estimate, and thus one cannot calculate
absolute steroid levels in the extracellular ﬂuid. Lastly, micro-
dialysis probe insertion causes injury to the brain, which may
induce neurosteroid synthesis (Garcia-Segura et al., 2001; Sal-
danha et al., 2009). This must be considered when interpreting
the results.
Many studies have investigated steroids produced by brain tis-
sue in vitro. These studies can examine steroid synthesis from
radiolabeled precursors, as well as measure endogenous steroid
levels in the conditioned medium and cultured tissue (organ-
otypic brain slices, minces, or dissociated cells; Gomez-Sanchez
et al., 1997; Holloway and Clayton, 2001; Hojo et al., 2004; Kretz
et al., 2004;Munetsuna et al., 2009;Higo et al., 2011). These in vitro
studies are very useful for investigating the regulation and func-
tions of neurosteroids. However, the levels of steroids produced
in vitro cannot directly reveal the levels of steroids in the brain
in vivo (Schlinger et al., 1994; Saldanha et al., 2009). Moreover,
creating brain slices or dissociating cells causes tissue injury and
thus might affect steroid production.
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EUTHANASIA
To directly measure steroid levels in various brain regions of ani-
mals, the brain must be collected after euthanasia of the subjects.
Importantly, the method of euthanasia can affect steroid concen-
trations in thebrain.The appropriatemethodof euthanasia should
minimize stress and discomfort of the subjects as well as min-
imize changes in brain steroid levels. These considerations will
vary depending on the nature of the experiment and the study
species. A further consideration is whether blood should be col-
lected and, if so, whether blood should be collected immediately
before or after euthanasia and how and from where blood should
be collected (Newman et al., 2008b).
Euthanasia is commonly performed by an overdose of an anes-
thetic. This method allows the animal to be subsequently perfused
with saline (to remove blood from the brain; see below). How-
ever, inducing a loss of consciousness via anesthetic requires an
alteration of neural activity (MacLusky, 2009), which might affect
brain steroid levels. The effects of anesthesia on brain steroids
can be speciﬁc to the anesthetic agent used. In rabbits, isoﬂu-
rane or halothane gas anesthesia may rapidly increase plasma
corticosterone and cortisol levels (González-Gil et al., 2006). How-
ever, in rats, carbon dioxide anesthesia for up to 2min does not
affect plasma corticosterone levels (Hackbarth et al., 2000). To our
knowledge, no studies have examined the acute effects (within
2–3min) of inhalant anesthesia on brain steroid measurements.
Effects of injectable anesthetics on brain steroids also appear to be
speciﬁc to the anesthetic used. For example, brain progestin levels
are increased by injection of chloral hydrate or urethane, but brain
progestin levels are decreased by pentobarbital, ketamine, or clon-
azepam (Korneyev et al., 1993a). Dramatic changes occur within
30min, and in some cases within 10min (Korneyev et al., 1993a).
Again, however, we know of no studies examining the acute effects
of injectable anesthetics on brain steroid measurements. Thus,
when necessary and appropriate, anesthesia should be performed
as rapidly as possible andwith amethod thatminimizes changes in
steroid levels. The stressors of handling and transfer into a novel
cage for anesthesia may themselves cause rapid steroid changes.
These stressors can be minimized by regular handling in the days
prior to anesthesia or by administration of anesthesia in the home
cage (e.g., Reburn and Wynne-Edwards, 2000).
Physical euthanasia without anesthesia does not depend on
chemical alteration of nervous system activity (Karmarkar et al.,
2010), and examples include decapitation or cervical dislocation
without prior anesthesia (American Veterinary Medical Associa-
tion, 2007). Loss of consciousness following decapitation is rapid
(within seconds) and humane (Holson, 1992; Rijn et al., 2011),
although some brain electrical activity can be recorded for up to
1min (Rijn et al., 2011),which could potentially alter steroid levels.
Rapid cooling of brain tissue might prevent such neurochemical
changes, if present.
Euthanasia can also be performed by head-focused microwave
irradiation, which rapidly heats the brain to cause extremely
rapid loss of consciousness while maintaining physical integrity
(Murphy, 2010). Heat inactivation stops enzymatic activity, thus
rapidly halting lipid metabolism (Murphy, 2010) and changes in
protein phosphorylation (O’Callaghan and Sriram, 2004), which
otherwise continue after physical euthanasia. Focused microwave
irradiation is thus potentially useful for preventing continued
steroid metabolism and has been used in a few studies of brain
steroid levels (e.g., Korneyev et al., 1993a,b; Barbaccia et al., 1996;
Concas et al., 2000).
To our knowledge, no studies have directly compared different
methods of euthanasia and their effects on brain steroid levels.
Such data would be very useful for researchers selecting the best
method of euthanasia for an experiment.
PERFUSION WITH PHYSIOLOGICAL SALINE
In some studies, it may be important to remove blood contamina-
tion from the brain. This can be achieved via transcardial perfu-
sion with physiological saline (following anesthesia). For example,
saline perfusion is often performed prior to tissue ﬁxation for
immunohistochemistry. Also, removal of blood contamination
might give a more accurate estimate of steroid concentrations in
the brain tissue (i.e., without steroids in the blood; Taves et al.,
2010). This issue has been experimentally examined in rats, mice,
and songbirds. In neonatal rats and adult mice, saline perfusion
has no effects on brain 17β-estradiol and corticosterone levels,
respectively (Amateau et al., 2004; Little et al., 2008). However,
in adult zebra ﬁnches, saline perfusion increases brain corticos-
terone levels, decreases brain DHEA levels, and increases brain
17β-estradiol levels in a region-speciﬁc manner, possibly due to
rapid effects of ischemia (Taves et al., 2010). Such steroid changes
might be minimized by perfusion with oxygenated artiﬁcial CSF.
Thus,when necessary, perfusion should be performed as rapidly as
possible. Furthermore, because saline perfusion does not cause a
global decrease in brain steroid levels, blood contamination (∼1%
of brain, v/w) does not appear to signiﬁcantly affect brain steroid
measurements (Taves et al., 2010). Prior to an experiment, vali-
dations should be performed to ensure that saline perfusion does
not affect brain steroid levels.
DISSECTION
For measurement of brain steroid concentrations, nearly all stud-
ies have used gross dissection of tissue blocks that contain brain
regions of interest (e.g., Butte et al., 1972; Caruso et al., 2008; Croft
et al., 2008; Newman and Soma, 2009; Brummelte et al., 2010). To
do this, the brain can be brieﬂy cooled onwet ice, and then a scalpel
blade is used to cut blocks of tissue based on their position relative
to major neuroanatomical landmarks (e.g., midline, ventricles).
Large areas, such as the cerebral cortex or hippocampus, can be
subdivided as appropriate. Typically, tissue blocks are then frozen
on dry ice and stored at −80˚C. Such tissue blocks are relatively
large,which increases the likelihood that steroids will be detectable
in the sample and might also allow a greater number of steroids to
be measured in a single sample. The major disadvantage of gross
dissection is the loss of neuroanatomical speciﬁcity. Additionally,
gross dissection by hand could increase the variability in the size
of tissue samples across subjects.
Microdissection of speciﬁc brain regions allows for a higher
degree of spatial speciﬁcity of brain steroid measurements (Maga-
riños et al., 1989). Recently, microdissection of brain nuclei using
the Palkovits punch technique (Palkovits, 1973; de Kloet, 2006)
has been used for measurement of brain steroid concentrations
(Charlier et al., 2010, 2011). Here, the whole brain is immediately
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frozen on powdered dry ice and stored at −80˚C. The brain is
then covered in an embedding matrix intended for sectioning at
a relatively warm temperature (e.g., Tissue-Tek O.C.T.), and brain
sections (200–500μm) are cut on a cryostat at −12 to −10˚C.
The sections should be kept frozen at all times. Locations of spe-
ciﬁc brain nuclei can be determined using major neuroanatomical
landmarks and a brain atlas. Sections containing nuclei of interest
are mounted onto glass microscope slides, and cannulae (kept at
−10˚C or colder) are used to punch out tissue from the sections.
The sections can then be stained with a Nissl stain to verify the
locations of the punches (Charlier et al., 2010).
Microdissection has several advantages over gross dissection.
Since the whole brain is frozen immediately after removal from
the cranium, the amount of postmortem steroid metabolism is
reduced. Additionally, microdissection allows for more precise
targeting of speciﬁc brain nuclei. Finally, tissue samples are of
a uniform size, which reduces between-subject variability in the
amount of brain tissue per sample. A disadvantage of microdis-
section is that the tissue samples can be small (often <1mg), and
thus ultrasensitive assays are necessary to measure steroids in such
small samples (Charlier et al., 2010). If the assays are also very
precise, then samples need not be measured in duplicate (i.e., can
be measured as singletons), which can be useful when the amount
of sample is limited (Charlier et al., 2011). Note also that inter-
mediate levels of spatial speciﬁcity can be achieved using a “brain
matrix”(e.g., Ted Pella, #15007; Soma et al., 2005) or a tissue chop-
per (e.g., Ted Pella, #10180), followed by additional dissectionwith
a scalpel or cannula.
Regardless of the method used to collect brain tissue, the
amount of steroid in each sample must be corrected for the
amount of tissue (typically wet weight in grams; see below). With
gross dissection, each sample must be weighed on a microbalance.
With Palkovits punch microdissection, however, all samples are
of known thickness and diameter, and thus are of similar weight
(Charlier et al., 2011). For example, when using a 1-mm-diameter
cannula (Fine Science Tools, #18035-01) on 300μm song spar-
row brain sections, we have empirically determined that one brain
punch has a mean wet weight of 0.245mg (and protein content of
0.02mg), with very little variation.
STEROID EXTRACTION
TISSUE HOMOGENIZATION
Once brain tissue samples have been collected, steroids must be
extracted before they can be quantiﬁed (Newman et al., 2008a).
This is especially critical in tissues such as brain that have very
high lipid content, since lipids can interfere with steroid mea-
surement (Rash et al., 1980). Prior to steroid extraction, tissue
samples should be homogenized. To reduce potential metab-
olism of steroids in the tissue, tissue homogenization can be
performed in ice-cold water and followed immediately by addi-
tion of an organic solvent such as methanol. Homogenization
can also be performed in a water/methanol solution. Homoge-
nization can be performed with a microcentrifuge tube and ﬁtted
pestle (Charlier et al., 2010), an electric hand-held homogenizer
(e.g., Fisher Scientiﬁc PowerGen 125, #3396001; Newman and
Soma, 2009; Taves et al., 2010), or bead mill homogenizer (e.g.,
Omni Bead Ruptor 24, #19-101).We have found that each of these
homogenization techniques results in a similar mean steroid con-
centration, although the bead mill homogenizer increases sample
throughput andappeared toproduce less variability across samples
in a pilot study (unpublished results). Bead mill homogenization
also prevents cross-sample contamination. To further ensure dis-
ruption of cells, tissue can be homogenized in lysis buffer (Konkle
and McCarthy, 2011), or homogenized samples can be placed in a
sonicator.
STEROID EXTRACTION
Following tissue homogenization, steroids must be extracted to
separate them from other components of the brain sample, espe-
cially other lipids. Liquid–liquid extraction with organic solvents
(e.g., diethyl ether) has long been used to isolate steroids, and
is still frequently used. However, with liquid–liquid extraction,
steroid recoveries can be low or variable, depending on the sample
type and steroids of interest (Appelblad and Irgum, 2002). Liquid–
liquid extraction can also extract other substances (i.e., other lipids
in the brain; Appelblad and Irgum, 2002). These problems can
impair accurate measurement of steroids in brain tissue samples.
For these reasons, liquid–liquid extraction is being replaced by
solid phase extraction over time (Makin and Gower, 2010), or can
be paired with solid phase extraction (below; Chao et al., 2011).
Solid phase extraction of brain steroids typically involves load-
ing the sample (in an aqueous buffer) onto a primed and equi-
librated sorbent (e.g., silica-bonded C18; Telepchak et al., 2004).
We have found C18 columns with 500mg packing material (e.g.,
Agilent Bond Elut LRC-C18 OH, #12113045) mounted on a glass
vacuum manifold (UCT #VMF024GL) to be suitable. After col-
umn priming and sample loading are completed, the sample is
thoroughly washed to remove interfering substances (Appelblad
and Irgum, 2002). With the correct wash(es), interfering sub-
stances can be effectively removed, while maintaining high steroid
recoveries (Newman et al., 2008a). The selection of an effec-
tive wash step is dependent on the analyte, study species, tissue
type, and method for steroid quantiﬁcation (e.g., immunoas-
say, LC–MS/MS). Work in our laboratory, which has focused on
unconjugated steroids, has found that washing with 10ml deion-
ized water is sufﬁcient for songbird brain samples, but washing
with 10ml 40% methanol is required for mouse and rat brain
samples (Figure 1). This might be related to species differences
in brain lipid content. Note that 40% methanol also elutes con-
jugated (e.g., sulfated, glucuronidated) steroids (Bélanger et al.,
1990; Wang et al., 1997; Liere et al., 2000). More stringent washes
(e.g., 40% methanol, or deionized water followed by hexanes)
may also be required if extracted steroids are to be separated by
high-performance liquid chromatography (HPLC).Afterwashing,
steroids are slowly eluted off the sorbent into borosilicate glass vials
or tubes. Elution of unconjugated steroids may be performed with
85–100% methanol, ethyl acetate, or one followed by the other
(Bélanger et al., 1990; Wang et al., 1997; Scott and Ellis, 2007;
Wong et al., 2008). Eluting unconjugated steroids with 85–90%
methanol might be useful because 100% methanol can also elute
steroids conjugated to fatty acids (Bélanger et al., 1990;Wang et al.,
1997; Liere et al., 2004). It is critical to use the appropriate grade of
solvents for solid phase extraction (e.g., HPLC-grade, MS-grade).
Finally, solid phase extraction can be automated with robotics
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FIGURE 1 | Solid phase extraction of steroids from increasing amounts
of brain tissue per assay tube. Samples were loaded onto C18 columns and
washed with 10ml of 0, 10, 20, or 40% methanol (MeOH) in water. Steroids
were then eluted from the C18 columns with 5ml of 90% MeOH. (A)The
different washes have no effect on measurement of 17β-estradiol (E2) in zebra
ﬁnch brain (Taves and Soma, unpublished data). (B)The different washes do
affect measurement of E2 in mouse brain (Taves and Soma, unpublished
data). (C)The different washes also affect measurement of corticosterone in
rat brain (adapted with permission from Brummelte et al., 2010). The methods
for all validations are similar (see Newman et al., 2008a). Brieﬂy, brain tissue
was homogenized in deionized water, and then MeOH was added. The
samples were mixed and then left overnight at 4˚C. The samples were mixed
again and centrifuged (3000 g, 10min, 2˚C). Supernatants (≤1ml) were
diluted with 10ml deionized water and loaded onto C18 columns (500mg C18,
non-endcapped). Prior to sample loading, the C18 columns were primed with
3ml ethanol and equilibrated with 10ml deionized water. After sample loading,
columns were washed with 0, 10, 20, or 40% MeOH (10ml) and steroids
were eluted with 5ml 90% MeOH. Eluates were dried in a vacuum centrifuge
and resuspended in assay buffer. All reagents were HPLC-grade. E2 was
measured using an ultrasensitive and speciﬁc radioimmunoassay (Beckman,
DSL-4800; Charlier et al., 2010), and corticosterone was also measured using
a radioimmunoassay (MP Biomedicals, cat. 07120103,Washburn et al., 2002).
to increase sample throughput (e.g., Gilson #GX-274 ASPEC or
Hamilton STARlet).
Solid phase extraction gives reliable recovery of very low
steroid amounts from small samples. The combination of high
steroid recovery and high precision make solid phase extraction
an extremely useful tool (Telepchak et al., 2004). It is critical to
routinely check the effectiveness of the extraction procedure. Note
that some brands of C18 columns can show lot-to-lot variation,
and thus it is preferable to extract all the samples from one exper-
iment with columns from the same lot. Furthermore, extraction
performance should not be tested solely with radiolabeled steroids
because this can overlook some problems. The use of only radi-
olabeled steroids ignores the potential co-elution of interfering
substances (originating from the sample itself or from the C18 col-
umn) and damage to the steroid analytes during processing (Scott
and Ellis, 2007). Thus, it is important to routinely check extraction
performance with unlabeled steroid standards (“quality controls”)
and water blanks.
After eluates have been collected, they can be dried at 40–
60˚C (Liere et al., 2000). We have found that drying at 50 or
60˚C reduces drying time without affecting steroid measurement
(Table 1; our unpublished results). Drying is typically done under
a stream of high-purity nitrogen with a sample concentrator (e.g.,
Techne Dri-Block DB-3) or in a vacuum centrifuge (e.g., Thermo
Scientiﬁc SPD111V SpeedVac). The dried steroid residue can then
be resuspended for quantiﬁcation, for example via immunoas-
say. We have found that a small amount of absolute ethanol
improves steroid resuspension into an aqueous buffer (Newman
et al., 2008a),but caremust be takenbecause ethanol (or impurities
therein) can affect some immunoassays (Ocvirk et al., 2009; Char-
lier et al., 2010). Alternatively, after solid phase extraction, steroids
can be separated via chromatography prior to quantiﬁcation (see
below).
CHROMATOGRAPHIC SEPARATION
CELITE COLUMN CHROMATOGRAPHY
The C18 columns used for solid phase extraction are relatively
short, and although they can separate conjugated steroids from
unconjugated steroids (Liere et al., 2004), they have little abil-
ity to separate different unconjugated steroids from each other
(e.g., separate testosterone from estradiol). In many cases, it is
useful to separate the steroids present in a brain tissue sample
prior to steroid measurement. Steroid separation allows several
steroids to be measured (e.g., via immunoassays) without splitting
the sample, which is useful when the tissue sample is small. Fur-
thermore, with immunoassays, antibody cross-reactivity can be a
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Table 1 | Effect of drying temperature on measured steroid values.
40˚C (%) 50˚C (%) 60˚C (%)
Cortisol 100 114 101
Corticosterone 100 108 113
Progesterone 100 96 103
Samples were dried in a preheated Thermo Scientiﬁc SPD111V SpeedVac. Sam-
ples dried at 40˚C (the most common temperature used across many laboratories)
were used as the baseline, and samples dried at 50 and 60˚C are expressed as
a percent of this baseline. Each value is the mean of three samples. Drying at
40, 50, and 60˚C took approximately 3.0, 2.5, and 2.0 h, respectively. Taves and
Soma, unpublished data.
concern (see below), and this concern can be alleviated by steroid
separation prior to assay (e.g., Close et al., 2010).
Celite columnchromatographyuses columnsor cartridges con-
taining celite (highly porous, diatomaceous earth). Samples are
loaded onto celite columns, and then different steroids are eluted
off with different organic solvents. Celite chromatography has suf-
ﬁcient resolving power to separate multiple steroids and has been
used in numerous studies of plasma and brain steroids (Wingﬁeld
and Farner, 1975; Corpéchot et al., 1981; von Schoultz et al., 1990;
Wang et al., 1997; Frye et al., 2000; Dinger and Frye, 2004; Rosario
et al., 2004; Pradhan et al., 2010b). Nonetheless, celite columns
have less resolving power than HPLC or gas chromatography.
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
High-performance liquid chromatography is often used to sepa-
rate steroids in a sample. Reversed-phase HPLC using a C18 HPLC
column (e.g., Waters SymmetryShield, 4.6mm× 250mm, 5μm
silica particles) is often used for such purposes, allowing multiple
steroids to be collected and measured,without the need to split the
sample (Figure 2). Furthermore, for immunoassays,HPLC separa-
tion removes potentially cross-reactive steroids, resulting in greater
conﬁdence in immunoassay measurements. HPLC often requires
minimal sample preparation, as steroids need not be derivatized
beforehand. This allows for fraction collection and quantiﬁcation
by immunoassay (Mensah-Nyagan et al., 1996; Munetsuna et al.,
2009), more extensive puriﬁcation and analysis (Mensah-Nyagan
et al., 1996; Liere et al., 2000, 2004), or subsequent analysis via
tandem mass spectrometry (Liu et al., 2003; Krone et al., 2010).
GAS CHROMATOGRAPHY
Steroid separation can also be done via gas chromatography, prior
tomass spectrometry (Vallée et al., 2000;Alomary et al., 2001). Gas
chromatography requires some sample preparation, as steroids are
generally derivatized prior to GC/MS analysis. While derivatiza-
tion can greatly increase sensitivity and aid in determination of
steroid structure, it can be a time-consuming process and can
convert conjugated steroids into unconjugated steroids (Soldin
and Soldin, 2009) or even convert cholesterol into steroids (Schu-
macher et al., 2008; Liere et al., 2009).Different conjugated steroids
(e.g., DHEA-sulfate and DHEA-glucuronide) may also be con-
verted into the same form, resulting in conjugate misidentiﬁcation
(Liu et al., 2003). Additionally, the derivatization process is chal-
lenging to automate, which reduces sample throughput (Krone
et al., 2010). Nonetheless, GC/MS is well suited for the identiﬁca-
tion of novel steroidal compounds (Krone et al., 2010). Further, the
National Institute of Standards and Technology (NIST) GC/MS
database search capability is a powerful tool to aid in the discovery
and analysis of novel steroids.
STEROID QUANTIFICATION
IMMUNOASSAYS
Immunoassays include both radioimmunoassays (RIA) and
enzyme-linked immunosorbent assays (ELISA, also known as,
EIA). Immunoassays are still the most common way to mea-
sure steroids, because of their rapidity, simplicity, sensitivity, and
cost-effectiveness. Furthermore, many RIA and ELISA kits for
steroids are commercially available, contributing to the popularity
of immunoassays. Many commercially available RIA kits can be
modiﬁed to greatly increase their sensitivity. For example, we have
modiﬁed a double-antibody 125I RIA kit to detect sub-picogram
amounts of 17β-estradiol (Charlier et al., 2010). This modiﬁed
assay is also accurate, speciﬁc, and precise. Samples are usually
measured in duplicate, requiring the sample to be split in half, but
the high precision of this estradiol assay allows samples to be run
as singletons, which is useful when the sample is limited (Charlier
et al., 2011).
There are some disadvantages associated with the use of
immunoassays. One limitation is antibody cross-reactivity, partic-
ularly with polyclonal antibodies. Antibodies exhibit widely vary-
ing degrees of speciﬁcity for their antigen and may bind molecules
other than the target of interest, such as closely related steroids
(Chard, 1995). Several measures can alleviate concerns about anti-
body cross-reactivity: selection of a speciﬁc antibody, checking
closely related steroids for antibody binding, and chromatographic
separation of steroids prior to immunoassay.
Another potential problem is that different matrices can
affect antibody binding. Most commercially available steroid
immunoassay kits are designed to measure steroids in unextracted
plasma, serum, or saliva samples, and thus the standards in the
standard curve contain the steroid in an appropriate matrix (i.e.,
similar to serum or saliva). However, when steroids in brain sam-
ples are extracted and resuspended in an aqueous buffer that does
not contain serum or saliva components (e.g., phosphate-buffered
saline with gelatin, PBSG), the antibody can show increased bind-
ing to the analyte (possibly due to reduced matrix interference).
Thus, extracted steroids resuspended in PBSG should be compared
to a standard curve that is also diluted in PBSG. These “matrix
effects” can affect steroid measurements, especially at low steroid
concentrations.
MASS SPECTROMETRY
Mass spectrometry, following either gas or liquid chromatography,
is highly speciﬁc and is currently the “gold standard” for deﬁnitive
identiﬁcation of analyte molecules (Alomary et al., 2001; Soldin
and Soldin, 2009; Makin and Gower, 2010). Mass spectrometry
also allows for simultaneous measurement of many steroids in a
single sample, or “steroid proﬁling” (Liu et al., 2003; Ebner et al.,
2006; Meffre et al., 2007; Soldin and Soldin, 2009; Koren et al.,
submitted). This can now be used to measure both unconjugated
steroids and intact steroid sulfates and glucuronides (Jäntti et al.,
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FIGURE 2 | High-performance liquid chromatography separation of (a)
cortisol, (b) corticosterone, (c) 11-deoxycortisol, and (d)
11-deoxycorticosterone.To separate these glucocorticoids, we used
reversed-phase HPLC (Gilson 322) with aWaters SymmetryShield C18 column
(4.6mm×250mm, 5μm silica particles). The mobile phase consisted of 50%
HPLC-grade methanol in HPLC-grade water with 0.01% glacial acetic acid
(solvent A; indicated by the solid gray line at top). At 45min, 5% isopropanol
(solvent B; dashed gray line at the bottom) was added in order to elute the
ﬁnal peaks more rapidly. The solid black line indicates radioinert steroids
measured with a UV detector, and the dotted gray line indicates 3H-labeled
steroids measured with a radioﬂow detector (as described in Mensah-Nyagan
et al., 2008; Pradhan et al., 2008, 2010a). Detection of radiolabeled steroids
occurs 1.6min later than radioinert steroids because of the extra length of
tubing between the UV and radioﬂow detectors. A fraction collector was then
used to collect glucocorticoids for quantiﬁcation via enzyme immunoassay
(EIA) or radioimmunoassay (Taves et al., unpublished results).
2010). These characteristics have contributed to the growing use
of mass spectrometry (and tandem mass spectrometry) in steroid
analysis (Mensah-Nyagan et al., 1996; Grifﬁths et al., 2001; Liere
et al., 2004, 2009; Matsunaga et al., 2004;Wang et al., 2007; Caruso
et al., 2008; Krone et al., 2010).
The sensitivity of mass spectrometry has greatly improved.
Steroids are typically derivatized prior to GC/MS to increase mea-
surement sensitivity, but this has some disadvantages (see above).
Steroids need not be derivatized prior to LC–MS/MS, although
this can be done to increase sensitivity and speciﬁcity (Higashi
and Shimada, 2004; Higashi et al., 2005; Higashi, 2006; Hojo
et al., 2009). Since the sensitivity of LC–MS/MS varies for different
steroids, derivatization can be used to aid detection of poorly ion-
ized steroids when they are present in low quantities. A variety of
derivatization methods can be used, depending on the analyte(s)
of interest (Santa, 2011). The method of ion production can also
affect sensitivity (Wang et al., 2007). For some steroids, atmos-
pheric pressure photo-ionization might yield greater sensitivity
than atmospheric pressure chemical ionization or electrospray
ionization (Robb et al., 2000; Guo et al., 2006). Nonetheless, when
the amount of brain tissue is extremely limited (e.g., punch sam-
ples or samples from neonatal rats) the limits of quantiﬁcation of
mass spectrometry may not be sufﬁcient (Konkle and McCarthy,
2011).
Thus, mass spectrometry provides deﬁnitive steroid identiﬁca-
tion, simultaneous multi-analyte quantiﬁcation and good sensi-
tivity. However, high equipment costs and operating costs and
the need for speciﬁc technical expertise are obstacles to using
mass spectrometry for steroid analysis (Makin and Gower, 2010;
Stanczyk and Clarke, 2010).
INTERPRETATION
COMPARING STEROID LEVELS IN THE BRAIN AND CIRCULATION
Many studies directly compare steroid levels in brain tissue with
steroid levels in the general circulation. In subjects that have been
adrenalectomized and/or gonadectomized for a long time, the
presence of a steroid in the brain, but not in the circulation, is
strong evidence for local steroid synthesis (Corpéchot et al., 1981;
Concas et al., 2000; Gomez-Sanchez et al., 2005; Croft et al., 2008;
Higo et al., 2011). Furthermore, in gonad- and adrenal-intact sub-
jects, if tissue steroid levels are higher than circulating steroid
levels, then these data suggest that steroids are locally synthe-
sized, locally sequestered by tissue binding sites, or locally released
from steroid binding proteins in the blood. These alternative pos-
sibilities can be tested, for example, by measuring steroidogenic
enzymes and/or steroid binding sites (Taves et al., 2011). Some
representativemeasurements of endogenous steroid levels in intact
adult male rats are given in Table 2.
When comparing steroid levels in the brain and circulation,
a critical point is that the use of plasma samples signiﬁcantly
overestimates steroid concentrations in the blood. Steroid con-
centrations in plasma are roughly twice as high as steroid con-
centrations in whole blood (Taves et al., 2010). Thus, for a more
representative measurement of actual circulating steroid levels, it
is informative to measure steroids in whole blood samples as well
as plasma samples (Figure 3).
Another issue is that most studies measure total steroid lev-
els (free+ bound) in brain and plasma samples. In the case of
corticosterone and cortisol, over 90% of these glucocorticoids
in plasma are bound with high afﬁnity to corticosteroid-binding
globulin, and are thus unable to readily enter tissues (Hammond,
1990; Breuner andOrchinik, 2002; Charlier et al., 2009). Since only
free (unbound) steroids are available to enter tissues, plasma free
steroid levels are also informative for comparison to tissue steroid
levels (as in Little et al., 2008; Figure 4).
If local steroid synthesis occurs at low levels or only in spe-
ciﬁc cells or subcellular compartments (e.g., mitochondria, pre-
synaptic terminals), then the average tissue steroid concentration
may be similar to or lower than the circulating steroid concentra-
tion (Newman and Soma, 2011). For all of the above reasons,when
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Table 2 | Selected measurements of endogenous steroid levels in adult male rat plasma or serum (ng/ml) and brain tissue (ng/g).
Steroid Plasma/serum Cortex Hippocampus Hypothalamus Cerebellum Whole brain
Pregnenolone n.d.–0.9 0.4–7.0 4.8 11–12 0.4–19 1.7–4.9
Progesterone 0.5–2.2 1.5–7.0 4.6 0.9 0.7–5.3 0.4–0.7
DHEA n.d.–0.1 0.2 0.1 1.5 0.2 0.2–0.3
Testosterone 1.2–4.2 0.1–2.6 4.9 14 2.3–2.4 1.4–2.2
17β-Estradiol n.d.–0.004 0.1 2.3 n.a. 0.02 n.d.
5α-DHT n.d.–0.2 n.d.–0.2 1.9 2.0 0.1 n.d.
Corticosterone 20–54 7.5 44 43 20 4.6–50
All brain steroid measurements were obtained after solid phase extraction. In some cases, steroid extracts were further puriﬁed using high-performance liquid chro-
matography, gas chromatography, or thin-layer chromatography. Steroids were quantiﬁed using radioimmunoassay or mass spectrometry. DHEA, dehydroepiandros-
terone; 5α-DHT, 5α-dihydrotestosterone; n.d., non-detectable; n.a., not assessed.Values compiled from Butte et al. (1972); Robel et al. (1973); Lanthier and Patwardhan
(1987); Purdy et al. (1991); Korneyev et al. (1993b); Wang et al. (1997); Vallée et al. (2000); Ebner et al. (2006); Meffre et al. (2007); Caruso et al. (2008); Hojo et al.
(2009); Pesaresi et al. (2010).
FIGURE 3 | Corticosterone and DHEA levels in zebra finch plasma,
whole blood, and brain (cTel, caudal telencephalon). For corticosterone,
brain levels are signiﬁcantly lower than plasma levels but not signiﬁcantly
lower than whole blood levels. For DHEA, brain and plasma levels are
similar, but brain levels are signiﬁcantly higher than whole blood levels.
Thus, the use of plasma samples (which overestimate circulating steroid
levels) or whole blood samples can lead to very different interpretations
when comparing tissue steroid levels against circulating steroid levels.
*p<0.05, ***p<0.001. Reprinted with permission fromTaves et al. (2010).
total steroid levels in brain tissue are similar to or even lower than
total steroid levels in plasma, one cannot exclude the possibility
of local steroid synthesis on the basis of this observation alone.
Other forms of evidence (e.g., steroidogenic enzyme expression)
are useful for interpreting such a pattern of results.
To facilitate comparison of brain and circulating steroid levels,
it is extremely useful to present brain steroid concentrations and
circulating steroid concentrations in comparable units (e.g., ng/g
wet weight for brain, ng/ml for plasma or whole blood). Note that
1ml of plasma or blood weighs very close to 1 g (Schmidt et al.,
2008; Taves et al., 2010). Some papers use different units for brain
steroid concentrations and plasma steroid concentrations (e.g.,
ng/mgprotein for brain,nM for plasma). This practice complicates
the comparison of brain and plasma steroid concentrations.
COMPARING STEROID LEVELS IN DIFFERENT BRAIN REGIONS
Within an individual brain, a comparison of steroid levels in dif-
ferent regions can identify which regions are most active as steroid
producers or targets (von Schoultz et al., 1990; Toran-Allerand
et al., 2005; Little et al., 2008; Newman and Soma, 2009; Char-
lier et al., 2010). This is important in identifying region-speciﬁc
effects of experimental treatment. For example, if an experimen-
tal treatment elevates steroid levels in a speciﬁc brain region, but
not in other brain regions or circulating blood, this indicates local
steroid production (or accumulation) in that speciﬁc region (e.g.,
Little et al., 2008). Comparing steroid levels across brain regions
is somewhat more straightforward than comparing steroid levels
between brain and blood.
EFFECTS OF PERIPHERAL STEROIDS ON BRAIN STEROID LEVELS
Measurement of local steroid concentrations is also useful for
understanding the neural effects of systemic steroids (endogenous
or exogenous). It is generally assumed that increases in systemic
steroid levels result in concurrent increases in steroid levels in
target tissues, but this is not necessarily the case. For example,
in rats, a rise in plasma corticosterone is followed by a rise in
brain corticosterone (as measured by microdialysis), but surpris-
ingly only after a 20-min delay (Droste et al., 2008). Systemically
administered steroids may also be metabolized before reaching
the brain or within the brain itself (Edinger and Frye, 2004), and
some steroids are preferentially excluded from the brain via active
transport by P-glycoprotein in the blood–brain barrier (Karssen
et al., 2001). By measuring steroid levels in target tissues (such
as brain), researchers can test whether a systemic steroid treat-
ment results in locally elevated steroid levels, and whether local
steroid levels are within the physiological range. Furthermore, as
some protein-bound circulating steroids have minimal access to
the brain (Pardridge and Mietus, 1979), systemic steroid treat-
ments that result in supraphysiological levels in the blood may
produce only moderately elevated steroid levels in the brain (e.g.,
Amateau et al., 2004). Finally, note that systemically administered
steroids can regulate the synthesis of neurosteroids (e.g., Soma
et al., 2004).
INADVERTENT INDUCTION OF STEROIDOGENIC ENZYMES IN THE
BRAIN
Injuries to brain tissue can have rapid and enduring effects on
steroidogenic enzyme activities around the damaged brain tissue.
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FIGURE 4 |Theoretical comparison of circulating and tissue steroid
concentrations. (A) If the same amounts of steroid are present in equal
volumes of blood and brain, different interpretations can be made,
depending on how steroids are quantiﬁed in blood. In the circulation, the
vast majority of corticosterone is bound to corticosteroid-binding globulin
(CBG; Hammond, 1990). CBG-bound steroids have very limited access to
tissue and limited ability to cross the blood–brain barrier. (B) Corticosterone
concentrations in whole blood are approximately 50% of those in plasma
(Taves et al., 2010), and within plasma, the vast majority of corticosterone is
bound to CBG. In the above theoretical scenario, if whole blood
corticosterone is measured, then circulating levels appear identical to tissue
levels. If plasma total corticosterone is measured, then circulating levels
appear much higher than tissue levels. If plasma free corticosterone is
measured, then circulating levels appear much lower than tissue levels.
Thus, the use of whole blood steroid measurements or plasma free steroid
measurements is highly informative in addition to plasma total steroid
measurements.
For example, aromatase is expressed constitutively in avian and
mammalian neurons (Balthazart et al., 1993; Naftolin et al., 1996;
Saldanha et al., 2000), but neuropil perturbation, such as by
excitotoxicity (Azcoitia et al., 2001), penetrating injury (Garcia-
Segura et al., 1999; Peterson et al., 2001), or anoxia/ischemia
(Garcia-Segura et al., 2001), induces additional aromatase expres-
sion in astroglia around the site of primary damage (Saldanha
et al., 2010). This induction of aromatase occurs in hours and
lasts weeks (Wynne et al., 2008) or months post-injury (Garcia-
Segura et al., 2001). Importantly, this induction occurs in a
cell type that only expresses aromatase in vitro or following
damage to the brain (Schlinger et al., 1994; Zwain and Yen, 1999;
Saldanha et al., 2009). Thus, when experimental techniques that
cause physical damage of neural tissue are used, measured steroid
levels likely reﬂect a combination of constitutive and induced
estrogen levels. Such techniques could include brain slicing or
dissociation prior to tissue culture, microdialysis probe or can-
nula insertion, saline perfusion, or a delay between euthanasia
and brain freezing. Increases in brain estradiol levels occur within
minutes of insult (Saleh et al., 2004; Taves et al., 2010). Other
steroids might also be altered during routine tissue collection
procedures.
CONCLUSION AND FUTURE DIRECTIONS
Numerous studies havemeasured steroids in plasma or serum, and
many studies have examined steroidogenic enzyme expression in
the brain. However, far fewer studies have measured steroids in
the brain. For example, many more studies have measured aro-
matase than estradiol levels in the brain. However, measurement
of tissue steroid concentrations is critical to understanding the
numerous roles and regulation of steroid signaling molecules in
the brain. Such measurements involve tissue collection, steroid
extraction, and steroid separation and quantiﬁcation. At each of
these steps, there are various methodological approaches that may
be used, and the selection of a particular approach necessitates
weighing the costs and beneﬁts of each, with respect to the goals
of the particular experiment. If the results obtained with differ-
ent approaches converge to give the same conclusion, then this is
strong evidence for a given phenomenon. Thus, the use of various
methods within a laboratory or across different laboratories can
be useful.
Improvements in steroid extraction and detection are steadily
increasing our ability to measure extremely small quantities
of steroids (<0.5 pg of steroid in a sample). Improved mea-
surement sensitivity allows for techniques that measure steroids
in samples that are of minimal size (e.g., brain punch sam-
ples, smaller microdialysate samples, CSF samples from human
infants, tumor biopsies), which can improve the spatial and tem-
poral resolution of brain steroid measurements. Laser capture
microdissection gives excellent spatial speciﬁcity (de Kloet, 2006),
and improved assay sensitivity might permit use of this tech-
nique for steroid quantiﬁcation in brain tissue. Similarly, in vivo
microdialysis provides temporal information about brain steroid
changes, and improved assay sensitivity will permit the use of
shorter dialysate collection windows, providing greater temporal
resolution.
In the future, other methods of measuring steroids in the brain
could be useful. For example, immunohistochemistry might allow
for even greater spatial information about steroids in the brain,
particularly at synapses. A few studies have quantiﬁed steroids via
immunohistochemistry using speciﬁc antibodies in ﬁxed neural
and non-neural tissues (Dornhorst and Gann, 1978; Saalmann
et al., 2007; Tokuda et al., 2011). It is critical that the necessary
controls be run (e.g., pre-absorption controls, tissues lacking the
steroid of interest) to convincingly demonstrate the speciﬁcity of
antibody binding in sample tissues.
In addition to quantifying well-known steroids, future studies
will undoubtedly discover novel steroids, steroid conjugates,
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and steroid metabolites. GC/MS is especially suited for such
exploratory analyses (Krone et al., 2010). The need for
identiﬁcation of novel steroids and steroidmetabolites is well illus-
trated by the case of brain estradiol, whose downstream metab-
olism remains unclear (Cornil, 2009; Charlier et al., 2011). Note
that local steroid metabolism is likely to affect local steroid lev-
els (Jäntti et al., 2010; Charlier et al., 2011). Such studies, along
with improvements in steroid proﬁling and measurement sensi-
tivity, promise to provide a much more detailed understanding of
regional and cellular differences in steroid synthesis, action, and
metabolism in the brain.
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